SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as the community anticipates the Q3 delivery report, with discussions focusing on whether the numbers will justify the stock's valuation and if the expiring EV tax credit has pulled sales forward. Bullish sentiment anticipates a delivery beat and a continued rally, while bears are wary of a potential "sell the news" event and question the company's fundamentals. Many are pointing to TSLA not being a car company but a "technology" company to justify any sales numbers.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian's stock is trending amidst discussions about narrowed delivery guidance and community speculation on its potential impact. Investors are weighing positive factors such as increased deliveries and the upcoming R2 vehicle against concerns about tax credit expiration and competition. Community members are actively debating the company's future prospects and potential catalysts, like the VW partnership.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

APLD is trending as investors discuss the company's potential, particularly highlighting progress on commissioning new data centers and the anticipation of a hyperscaler deal announcement. The community is buzzing with bullish sentiment, envisioning significant revenue growth and comparing APLD to other successful stocks in the AI and data center space. Some traders are discussing potential upcoming earnings and the possibility of a short squeeze.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing community backlash and a potential boycott after concerns about its content, particularly regarding children's programming and transgender themes, gained traction on social media and sparked commentary from public figures. Some users are canceling subscriptions and advocating for others to do the same, citing concerns about "woke" content and perceived agendas, while others defend the platform's diversity and the right to choose content. The controversy coincides with tariff concerns, contributing to market volatility around the stock.

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending due to positive Phase 2 results for its schizophrenia drug ANAVEX3-71, with discussions focusing on its safety profile and potential disease-modifying effects. The community is debating the implications of biomarker data and a once-daily oral tablet formulation, while also speculating on EMA approval timelines for its Alzheimer's drug, Blarcamesine. Some traders express skepticism, citing historical stock suppression, while others see a buying opportunity amidst the positive news.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members highlight its focus on culture, freedom, and global connection. Some users are drawing comparisons to Bitcoin, emphasizing Weedcoin's potential and unique utility. Community discussions also mention its underlying technology and potential for real-world applications.

Angel Studios, Inc. is a values-based distribution company for stories that amplify light to mainstream audiences. The company is headquartered in Provo, UT.

Angel Studios Inc. - Ordinary Shares - Class A

Angel Studios Inc

Angel Studios ($ANGX) is trending as the community discusses its recent public debut and potential for growth, with some drawing comparisons to Netflix and highlighting its unique community-driven model. Bullish sentiment is fueled by the company's growing guild membership and its bitcoin holdings. Some traders are weighing short-term volatility against long-term potential, while others are excited about the company's upcoming movie releases.

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.

Kazia Therapeutics Limited - ADR

Kazia Therapeutics

KZIA is trending due to promising preclinical data suggesting its drug paxalisib can overcome immunotherapy resistance in triple-negative breast cancer, potentially enhancing treatment effectiveness. Community discussions revolve around the significance of these findings and whether it could lead to future gains. Some traders are wary of the stock's history and potential for dilution while others highlight the positive news and low float.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber ($WYFI) is trending as investors discuss its potential in the data center and AI infrastructure space, especially after a recent IPO and analyst upgrades. The community is buzzing about a possible upcoming news catalyst related to their North Carolina facility and potential customer acquisitions, drawing comparisons to sector peers like $CRWV and $NBIS. Discussions also involve the relationship with major shareholder $BTBT and the potential for future offerings.

Fermi LLC engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi (FRMI) is trending following its IPO, with shares climbing after a strong market debut. The company's focus on powering AI data centers with natural gas and nuclear energy is sparking interest, and the community is discussing its potential and valuation relative to other companies in the sector. Some are noting the involvement of Rick Perry, former U.S. Energy Secretary.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aura Biosciences' Bladder Cancer Candidate Demonstrates Tumor Shrinkage In Patients With High-Grade Disease

Aura Biosciences released early Phase 1 trial data on bel-sar for non-muscle-invasive bladder cancer, showing promising clinical activity and a favorable safety profile.
read more...

Aura Biosciences Inc: A Buy Rating on Strong Pipeline and Financial Health

Andrew Berens, an analyst from Leerink Partners, maintained the Buy rating on Aura Biosciences Inc (AURA Research Report). The associated price t...

Aura Biosciences (AURA, $7.7) Aroon Indicator entered a Downtrend on March 27, 2024.

For the last three days, A.I.dvisor has detected that AURA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Recap: Aura Biosciences Q4 Earnings

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors to preserve the function of the afflicted organ with cancer...

Contrasting Aura Biosciences (NASDAQ:AURA) and Atara Biotherapeutics (NASDAQ:ATRA)

Aura Biosciences (NASDAQ:AURA  Get Free Report) and Atara Biotherapeutics (NASDAQ:ATRA  Get Free Report) are both small-cap medical companies, but which is the better investment? We...

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing a novel class of virus-like drug conjugate (VDC) therapies for multiple oncology indications, today announced...

Aura Biosciences (AURA, $8) Aroon Indicator entered a Downtrend on February 13, 2024.

Commit To Purchase Aura Biosciences At $7.50, Earn 32.6% Annualized Using Options

Investors considering a purchase of Aura Biosciences Inc (AURA) shares, but cautious about paying the going market price of 8.25/share, might benefit from considering selling puts among the...

Aura Biosciences (AURA, $8.9) Aroon Indicator entered a Downtrend on February 12, 2024.

Aura Biosciences, Inc. is a clinical-stage oncology company, which engages in developing a novel technology platform based on virus-like drug conjugates (VDCs) to target and destroy cancer cells selectively while activating the immune system to create long lasting anti-tumor immunity. The firm's product candidate belzupacap sarotalocan (AU-011) is in Phase 2 development for the first line treatment of choroidal melanoma, a vision and life-threatening form of eye cancer where standard of care radioactive treatments leave patients with major vision loss and severe comorbidities. The was founded by Elisabet de los Pinos in 2007 and is headquartered in Boston, MA.

Aura Biosciences Inc

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$6.13
Prev Close	$6.15
Open	$6.13
Dividend Yield	0.00%
50-Day Moving Average	$6.51
Beta	1.14
Avg. Volume	274,741.52
PE Ratio	-3.14

52-Week High	$12.38
52-Week Low	$4.35
Market Capitalization	$382.04M
EPS (Annual)	-$1.75
Price to Book	2.19
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

AURA
Aura Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AURA News

AURA Aura Biosciences Inc